Invention Grant
- Patent Title: Combination therapy
-
Application No.: US16613638Application Date: 2018-05-22
-
Publication No.: US11304953B2Publication Date: 2022-04-19
- Inventor: Daniel P. Gold
- Applicant: MEI Pharma, Inc.
- Applicant Address: US CA San Diego
- Assignee: MEI Pharma, Inc.
- Current Assignee: MEI Pharma, Inc.
- Current Assignee Address: US CA San Diego
- Agency: Wilson Sonsini Goodrich & Rosati
- International Application: PCT/US2018/033936 WO 20180522
- International Announcement: WO2018/217787 WO 20181129
- Main IPC: A61K31/5377
- IPC: A61K31/5377 ; A61P35/04 ; A61K9/00 ; C07K16/28
Abstract:
Provided herein are methods of treating diseases, such as cancer, using a combination therapy. In certain embodiments, the methods comprise administering an effective amount of a phosphoinositide-3-kinase (PI3K) inhibitor and an effective amount of a PD-1 or PD-L1 inhibitor to a patient.
Information query
IPC分类:
